Michael Alfieri's Net Worth
-$5.4 Thousand
Who is Michael Alfieri?
Michael Alfieri does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include GENOCEA BIOSCIENCES, INC., and PROTEOSTASIS THERAPEUTICS, INC..
SEC CIK
Michael Alfieri's CIK is 0001744687
Past Insider Trading and Trends
2018 was Michael Alfieri's most active year for acquiring shares with 1 total transactions. Michael Alfieri's most active month to acquire stocks was the month of January. 2018 saw Michael Alfieri paying a total of $5,400.00 for 10,000 shares, this is the most they've acquired in one year.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GENOCEA BIOSCIENCES, INC. No price found
Principle Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
∞
| 10K |
$0.54 | $5,400.00 | 10K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PROTEOSTASIS THERAPEUTICS, INC. (KA) Snapshot price: $0.65
Interim Head Finance
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aldeyra Therapeutics, Inc. (ALDX) No price found
Principal Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||